Company News 

BATS boosted by FDA delay

BATS boosted by FDA delay

British American Tobacco (BATS), in common with several industry peers, saw its shares jump after the US Food and Drug Administration (FDA) delayed plans to reduce nicotine levels in cigarettes to levels deemed non-addictive.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now